Mosaic Variegated Aneuploidy syndrome 2 caused by biallelic variants in CEP57, two new cases and review of the phenotype

Eur J Med Genet. 2021 Nov;64(11):104338. doi: 10.1016/j.ejmg.2021.104338. Epub 2021 Sep 7.

Abstract

Mosaic Variegated Aneuploidy Syndrome 2 (MVA2; MIM 614114) is a rare autosomal recessive disorder, characterized by mosaic aneuploidies involving multiple chromosomes and tissues, caused by biallelic pathogenic variants in the CEP57 gene. Only 10 patients have been reported to date. We report two additional non related cases born to Moroccan consanguineous parents, carrying the previously described c.915_925dup11 CEP57 homozygous variant. Common features of these 12 cases include growth retardation, typically of prenatal onset, distinctive facial features, endocrine, cardiovascular and skeletal, abnormalities while malignancies have not been reported. This report describes the phenotypical spectrum of MVA2.

Keywords: CEP57; Cancer predisposition; Cardiovascular malformations; Growth retardation; MVA2.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Child
  • Chromosome Disorders / genetics*
  • Chromosome Disorders / pathology
  • Humans
  • Male
  • Microtubule-Associated Proteins / genetics*
  • Mosaicism
  • Mutation
  • Nuclear Proteins / genetics*
  • Phenotype*

Substances

  • CEP57 protein, human
  • Microtubule-Associated Proteins
  • Nuclear Proteins

Supplementary concepts

  • Mosaic variegated aneuploidy syndrome